BFC Planning’s Assembly Biosciences ASMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$963 Hold
41
– – ﹤0.01% 3169
2026
Q2
$1.13K Hold
41
– – ﹤0.01% 3122
2026
Q1
$1.14K Hold
41
– – ﹤0.01% 2722
2025
Q4
$1.39K Hold
41
– – ﹤0.01% 2719
2025
Q3
$1.05K Hold
41
– – ﹤0.01% 2616
2025
Q2
$743 Hold
41
– – ﹤0.01% 2494
2025
Q1
$392 Hold
41
– – ﹤0.01% 2536
2024
Q4
$647 Hold
41
– – ﹤0.01% 2462
2024
Q3
$621 Buy
+41
New +$624 ﹤0.01% 2458

Other funds holding ASMB

BFC Planning's ASMB Position: Q3 2026 in Review

BFC Planning held its Assembly Biosciences (ASMB) position steady in Q3 2026 at 41 shares worth $963. The position accounts for ﹤0.01% of the portfolio, ranked #3169.

BFC Planning first reported a position in ASMB in Q3 2024 and has held it in 9 quarters since. The position peaked at $1.39K in Q4 2025. 59 funds tracked by Wall St. Rank hold ASMB as of Q3 2026.

  • BFC Planning held 41 shares of Assembly Biosciences worth $963 as of Q3 2026.
  • BFC Planning left its Assembly Biosciences share count unchanged in Q3 2026.
  • Assembly Biosciences made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3169 holding.
  • BFC Planning first reported a position in Assembly Biosciences in Q3 2024 and has held it in 9 quarters since.
  • BFC Planning's Assembly Biosciences position peaked at $1.39K in Q4 2025.
  • 59 funds tracked by Wall St. Rank held Assembly Biosciences as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.